IP Library Patent Application 16488421
Patent Application
App. No. 16/488,421

CHARACTERIZATION OF S-ADENOSYL-L-METHIONINE-CONSUMING ENZYMES WITH 1-STEP EZ-MTASE: A UNIVERSAL COUPLED-ASSAY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/488,421
Abstract

Methods and kits are disclosed for measuring activity of a methyltransferase or a radical SAM enzyme or for screening for an inhibitor of a methyltransferase or a radical SAM enzyme, where the methods and kits comprise, respectively, deaminase TM0936 for a MTase coupled assay and deaminase PA3170 for a radical SAM coupled assay.

Claims (25)

1 . A method of measuring activity of a methyltransferase, comprising contacting the methyltransferase with S-adenosyl-L-methionine (SAM) and/or a fluorescent SAM analog to generate S-adenosyl-L-homocysteine (SAH), quantitatively catabolizing the SAH to S-inosyl-L-homocysteine (SIH) in the presence of deaminase TM0936, and measuring the SIH produced.

2 . The method of claim 1 , wherein the methyltransferase is a protein methyltransferase, a DNA methyltransferase or an RNA methyltransferase.

3 . The method of claim 1 , wherein the methyltransferase is a lysine methyltransferase, an arginine methyltransferase, a histone-lysine N-methyltransferase, a glycine N-methyltransferase or a sarcosine/dimethylglycine N-methyltransferase.

4 . The method of claim 1 , wherein the method is carried out at a pH between pH 5 and pH 10.

5 . The method of claim 1 , wherein the method is carried out in the presence of sinefungin.

6 . The method of claim 1 , wherein the methyltransferase activity is quantified by measuring a decrease of absorbance at 263 nm.

7 . The method of claim 1 , wherein the SAM is a fluorescent SAM analog.

8 . The method of claim 7 , wherein the fluorescent SAM analog is S-8-aza-adenosine-L-methionine (8-aza-SAM), and wherein the methyltransferase activity is quantified by measuring a decrease of fluorescence emission at 360 nm.

9 . The method of claim 1 , wherein the methyltransferase activity is measured from or within a biological sample.

10 . A method of screening for an inhibitor of a methyltransferase, comprising carrying out the method of claim 1 in the presence and in the absence of a candidate compound, wherein a decrease in the activity of methyltransferase in the presence of the candidate compound, compared to methyltransferase activity in the absence of the candidate compound, indicates that the candidate compound is an inhibitor of the methyltransferase.

11 . A kit for measuring the activity of a methyltransferase or a radical SAM enzyme, the kit comprising:

S-adenosyl-L-methionine (SAM) and/or fluorescent SAM analog; and

deaminase TM0936.

12 . The kit of claim 11 , wherein the fluorescent SAM analog is S-8-aza-adenosine-L-methionine (8-aza-SAM).

13 . A method of measuring activity of a radical SAM enzyme, comprising contacting the radical SAM enzyme with S-adenosyl-L-methionine (SAM) to generate 5′-deoxyadenosine (5DOA), quantitatively catabolizing 5DOA to 5′-deoxyinosine (5DOI) in the presence of the deaminase PA3170, and measuring the 5DOI produced.

14 . The method of claim 13 , wherein the method is carried out at a pH between pH 5 and pH 10.

15 . The method of claim 13 , wherein the reaction is carried out in the presence of sinefungin.

16 . The method of claim 13 , wherein the radical SAM enzyme activity is quantified by measuring a decrease of absorbance at 263 nm.

17 . The method of claim 13 , wherein the radical SAM enzyme activity is measured from or within a biological sample.

18 . A method of screening for an inhibitor of a radical SAM enzyme, comprising carrying out the method of claim 13 in the presence and in the absence of a candidate compound, wherein a decrease in the activity of radical SAM enzyme in the presence of the candidate compound, compared to radical SAM enzyme activity in the absence of the candidate compound, indicates that the candidate compound is an inhibitor of the radical SAM enzyme.

19 . A kit for measuring the activity of a radical SAM enzyme, the kit comprising:

S-adenosyl-L-methionine (SAM) and

deaminase PA3170.

20 . The method of claim 1 , wherein the contacting and catabolizing are done as a one-step method.

21 . The method of claim 20 , wherein the method is a high throughput screening method.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 10, 2024
From: ALBERT EINSTEIN COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 066255/0349 →